| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10970544 | Vaccine | 2007 | 10 Pages |
Abstract
Vaccinating adolescent girls against HPV is likely to be cost-effective. The main benefit of vaccination will be in reducing CC mortality. However, unless screening is modified, the treatment costs saved through vaccination will be insignificant compared to the cost of HPV immunization.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marc Brisson, Nicolas Van de Velde, Philippe De Wals, Marie-Claude Boily,